OBJECTIVE: This study was aimed at providing an analysis of the correlation between CD4/CD8 counts and some coagulation factors in HIV-Positive Iranian patients. METHODS: A case-control study on 58 HIV-infected patients and control group (58 healthy individuals). Patients and controls were matched for sex and age. In this study, several blood parameters were measured in 58 HIV-infected patients and the controls. Laboratory data were then measured including hemoglobin, platelets, homocysteine, serum levels of IgM and IgG antiphospholipid antibodies (aPL), IgM and IgG anticardiolipin antibotdies (aCL), and CD4(+) and CD8(+) cell count. RESULTS: The HIV-infected patients, compared to healthy controls, showed a significant decline in platelets, CD4 count and CD8 count (p<0.0001), and an increase of homocysteine (p<0.0001) and IgG aPL levels (p<0.0001). No statistical difference was found between patients with CD4 count ≤200 and CD4 count >200 in the evaluated variables. CONCLUSION: The results showed that thrombophilic abnormality in the form of hyperhomocysteinemia is more frequent in HIV-infected patients and should be considered by clinicians in view of an early diagnosis of the hypercoagulability state to prevent thrombotic complications.
OBJECTIVE: This study was aimed at providing an analysis of the correlation between CD4/CD8 counts and some coagulation factors in HIV-Positive Iranian patients. METHODS: A case-control study on 58 HIV-infectedpatients and control group (58 healthy individuals). Patients and controls were matched for sex and age. In this study, several blood parameters were measured in 58 HIV-infectedpatients and the controls. Laboratory data were then measured including hemoglobin, platelets, homocysteine, serum levels of IgM and IgG antiphospholipid antibodies (aPL), IgM and IgG anticardiolipin antibotdies (aCL), and CD4(+) and CD8(+) cell count. RESULTS: The HIV-infectedpatients, compared to healthy controls, showed a significant decline in platelets, CD4 count and CD8 count (p<0.0001), and an increase of homocysteine (p<0.0001) and IgG aPL levels (p<0.0001). No statistical difference was found between patients with CD4 count ≤200 and CD4 count >200 in the evaluated variables. CONCLUSION: The results showed that thrombophilic abnormality in the form of hyperhomocysteinemia is more frequent in HIV-infectedpatients and should be considered by clinicians in view of an early diagnosis of the hypercoagulability state to prevent thrombotic complications.
Authors: Richard D Semba; Nina Shah; Robert S Klein; Kenneth H Mayer; Paula Schuman; David Vlahov Journal: Clin Infect Dis Date: 2001-12-04 Impact factor: 9.079
Authors: J Constans; V Guérin; A Couchouron; M Seigneur; A Ryman; A D Blann; J Amiral; A Amara; E Peuchant; J F Moreau; I Pellegrin; J L Pellegrin; H Fleury; B Leng; C Conri Journal: Eur J Clin Invest Date: 1998-02 Impact factor: 4.686
Authors: Joseph O Mugisha; Leigh Anne Shafer; Lieve Van der Paal; Billy N Mayanja; Henry Eotu; Peter Hughes; Jimmy A G Whitworth; Heiner Grosskurth Journal: Trop Med Int Health Date: 2008-03-31 Impact factor: 2.622
Authors: R A Kaslow; J P Phair; H B Friedman; D Lyter; R E Solomon; J Dudley; B F Polk; W Blackwelder Journal: Ann Intern Med Date: 1987-10 Impact factor: 25.391
Authors: M Sorice; T Griggi; P Arcieri; A Circella; F d'Agostino; M Ranieri; R Modrzewska; L Lenti; G Mariani Journal: Thromb Res Date: 1994-02-15 Impact factor: 3.944